ORIGINAL RESEARCH
Accepted on 22 Sep 2025
Predictive Value of Early Changes in Serum CEA, CYFRA21-1, and SCC-Ag for Efficacy and Prognosis in Advanced Lung Squamous Cell Carcinoma Treated with First-Line Immunotherapy Combined with Chemotherapy
doi 10.3389/fonc.2025.1561602
- 129 views